Marlio Charles Mosseri - Net Worth and Insider Trading

Marlio Charles Mosseri Net Worth

The estimated net worth of Marlio Charles Mosseri is at least $14 Million dollars as of 2024-12-29. Marlio Charles Mosseri is the 10% Owner of Nuvectis Pharma Inc and owns about 2,612,000 shares of Nuvectis Pharma Inc (NVCT) stock worth over $14 Million. Details can be seen in Marlio Charles Mosseri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marlio Charles Mosseri has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Marlio Charles Mosseri

To

Marlio Charles Mosseri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marlio Charles Mosseri owns 1 companies in total, including Nuvectis Pharma Inc (NVCT) .

Click here to see the complete history of Marlio Charles Mosseri’s form 4 insider trades.

Insider Ownership Summary of Marlio Charles Mosseri

Ticker Comapny Transaction Date Type of Owner
NVCT Nuvectis Pharma Inc 2024-12-13 10 percent owner

Marlio Charles Mosseri Latest Holdings Summary

Marlio Charles Mosseri currently owns a total of 1 stock. Marlio Charles Mosseri owns 2,612,000 shares of Nuvectis Pharma Inc (NVCT) as of December 13, 2024, with a value of $14 Million.

Latest Holdings of Marlio Charles Mosseri

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCT Nuvectis Pharma Inc 2024-12-13 2,612,000 5.22 13,634,640

Holding Weightings of Marlio Charles Mosseri


Marlio Charles Mosseri Form 4 Trading Tracker

According to the SEC Form 4 filings, Marlio Charles Mosseri has made a total of 18 transactions in Nuvectis Pharma Inc (NVCT) over the past 5 years, including 18 buys and 0 sells. The most-recent trade in Nuvectis Pharma Inc is the acquisition of 17,000 shares on December 13, 2024, which cost Marlio Charles Mosseri around $79,900.

Insider Trading History of Marlio Charles Mosseri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marlio Charles Mosseri Trading Performance

GuruFocus tracks the stock performance after each of Marlio Charles Mosseri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marlio Charles Mosseri is -30.73%. GuruFocus also compares Marlio Charles Mosseri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marlio Charles Mosseri within 3 months outperforms 0 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Marlio Charles Mosseri's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Marlio Charles Mosseri

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 16 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.96 LIMIT LIMIT LIMIT LIMIT LIMIT

Marlio Charles Mosseri Ownership Network

Ownership Network List of Marlio Charles Mosseri

No Data

Ownership Network Relation of Marlio Charles Mosseri

Insider Network Chart

Marlio Charles Mosseri Owned Company Details

What does Nuvectis Pharma Inc do?

Who are the key executives at Nuvectis Pharma Inc?

Marlio Charles Mosseri is the 10 percent owner of Nuvectis Pharma Inc. Other key executives at Nuvectis Pharma Inc include director & Chairman & CEO Ron Bentsur , Chief Science and Business Off Enrique Poradosu , and Vice President & Finance Michael J. Carson .

Nuvectis Pharma Inc (NVCT) Insider Trades Summary

Over the past 18 months, Marlio Charles Mosseri made 14 insider transaction in Nuvectis Pharma Inc (NVCT) with a net purchase of 133,096. Other recent insider transactions involving Nuvectis Pharma Inc (NVCT) include a net purchase of 40,145 shares made by Ron Bentsur , a net purchase of 2,500 shares made by Enrique Poradosu , and a net sale of 2,755 shares made by Michael J. Carson .

In summary, during the past 3 months, insiders sold 2,755 shares of Nuvectis Pharma Inc (NVCT) in total and bought 92,621 shares, with a net purchase of 89,866 shares. During the past 18 months, 2,755 shares of Nuvectis Pharma Inc (NVCT) were sold and 176,854 shares were bought by its insiders, resulting in a net purchase of 174,099 shares.

Nuvectis Pharma Inc (NVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nuvectis Pharma Inc Insider Transactions

No Available Data

Marlio Charles Mosseri Mailing Address

Above is the net worth, insider trading, and ownership report for Marlio Charles Mosseri. You might contact Marlio Charles Mosseri via mailing address: 27 Ripplevale Grove, London X0 N1 1hs.

Discussions on Marlio Charles Mosseri

No discussions yet.